Paracetamol Oral Paediatric Suspension at 4.8% : Study of Acceptability and Safety.
NCT00434681
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
Fever
Pain
Interventions
DRUG:
paracetamol 4.8% paediatric oral suspension
Sponsor
Sanofi